author = {Diao, Ling. and Fang, Pan-Feng.}, title = {{Clinical progress of cell therapy in treating age-related macular degeneration}}, journal ={Clinical Trials in Degenerative Diseases}, volume ={4}, number ={2}, pages = {37-42}, doi = {10.4103/2542-3975.260958}, year = {2019}, abstract ={Age-related macular degeneration is a retinal degenerative lesion caused by cell atrophy and dysfunction of retinal pigment epithelium. The degeneration of retinal pigment epithelium cells further leads to the apoptosis of photoreceptor cells, causes vision deterioration and eventually even blindness. Age-related macular degeneration is one of the top three retinal diseases causing blindness in the world. In recent years, exogenous retinal pigment epithelium cell therapy has emerged as a breakthrough treatment for age-related macular degeneration disease. In this review, we will briefly introduce the policies and regulations of cell therapy and discuss the clinical progress in the treatment of age-related macular degeneration using retinal pigment epithelium cells. }, URL ={https://www.clinicaltdd.com/article.asp?issn=2542-3975;year=2019;volume=4;issue=2;spage=37;epage=42;aulast=Diao;t=6}, eprint ={https://www.clinicaltdd.com/article.asp?issn=2542-3975;year=2019;volume=4;issue=2;spage=37;epage=42;aulast=Diao;t=6} }